Facebook tracking pixel
G47.10
ICD-10-CM
Daytime Somnolence

Understanding Daytime Somnolence (Excessive Daytime Sleepiness or Hypersomnia): Explore its clinical significance, diagnostic criteria, and medical coding considerations for accurate healthcare documentation. Learn about the causes, symptoms, and treatment options for Excessive Daytime Sleepiness, including relevant ICD-10 codes and clinical documentation best practices for Hypersomnia. This resource helps healthcare professionals ensure accurate and comprehensive patient care related to Daytime Somnolence.

Also known as

Excessive Daytime Sleepiness
Hypersomnia

Diagnosis Snapshot

Key Facts
  • Definition : Difficulty staying awake during the day, leading to unintended sleep episodes.
  • Clinical Signs : Frequent yawning, nodding off, difficulty concentrating, morning headaches, irritability.
  • Common Settings : Primary care, sleep clinics, neurology clinics.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC G47.10 Coding
G47.80-G47.89

Other sleep disorders

Covers various sleep disturbances, including hypersomnia not due to other causes.

G47.10-G47.19

Hypersomnia

Includes diagnoses specifically related to excessive daytime sleepiness.

F51.0-F51.9

Nonorganic sleep disorders

May include daytime sleepiness related to psychological factors.

R53.83

Other malaise and fatigue

Can be used if daytime sleepiness is a symptom of general fatigue.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the daytime somnolence due to a known medical condition?

  • Yes

    Is it due to a sleep disorder?

  • No

    Is substance use involved?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Excessive sleepiness during the day.
Sudden sleep attacks, cataplexy may be present.
Breathing pauses during sleep, daytime fatigue.

Documentation Best Practices

Documentation Checklist
  • Daytime somnolence (ICD-10 G47.1, R53.83): Document Epworth Sleepiness Scale score.
  • Hypersomnia documentation: Include symptom onset, duration, and severity.
  • Excessive daytime sleepiness: Rule out medical causes (e.g., thyroid, anemia).
  • EDS, hypersomnia: Assess impact on daily activities, work, driving.
  • Document sleep study findings if conducted (polysomnography, MSLT).

Coding and Audit Risks

Common Risks
  • Unspecified Hypersomnia

    Coding for 'Daytime Somnolence' without identifying underlying cause (e.g., narcolepsy, OSA) leads to unspecified codes and lower reimbursement.

  • Insufficient Documentation

    Lack of detailed documentation supporting 'Excessive Daytime Sleepiness' impacts accurate code assignment and compliance audits.

  • Comorbidity Overlap

    EDS overlaps with depression, anxiety, or other sleep disorders, requiring careful coding to avoid inaccurate claims and denials.

Mitigation Tips

Best Practices
  • Improve sleep hygiene: Regular sleep schedule, dark room, avoid caffeine/alcohol before bed.
  • Document EDS symptoms: Severity, frequency, impact on daily life, Epworth Sleepiness Scale.
  • Rule out underlying causes: OSA, narcolepsy, restless legs syndrome, medication side effects. ICD-10 G47.1, R40.0
  • Consider a sleep study: Polysomnography, Multiple Sleep Latency Test for objective data. CPT 95810, 95805
  • Optimize treatment: CPAP for OSA, stimulants for narcolepsy, behavioral therapy. HCC V23

Clinical Decision Support

Checklist
  • Rule out narcolepsy (ICD-10 G47.419, G47.40). Document PSG/MSLT findings.
  • Assess for OSA (ICD-10 G47.33). Review AHI from sleep study.
  • Consider other sleep disorders. Document differential diagnosis (e.g., insomnia, RLS).
  • Review medications. Document drug-induced sleepiness (ICD-10 G94.1).

Reimbursement and Quality Metrics

Impact Summary
  • **Reimbursement and Quality Metrics Impact Summary for Daytime Somnolence (Excessive Daytime Sleepiness, Hypersomnia)**
  • ICD-10 Coding: Accurate coding (G47.10, R53.83) impacts reimbursement for EDS evaluations and treatment.
  • Medical Billing: Proper documentation supports justification for polysomnography and MSLT for accurate billing.
  • Hospital Reporting: Daytime sleepiness data affects quality metrics related to patient safety and outcomes.
  • Impact on Healthcare Costs: Effective diagnosis and management of hypersomnia can reduce long-term healthcare utilization.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes for . Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: How can I differentiate between daytime somnolence caused by insufficient sleep and a medical condition like idiopathic hypersomnia or narcolepsy in my adult patients?

A: Differentiating between insufficient sleep and medical conditions causing excessive daytime sleepiness (EDS) requires a thorough patient history, including sleep diaries, and assessment of sleep hygiene. Look for red flags like sudden sleep attacks (narcolepsy), long sleep times without feeling refreshed (idiopathic hypersomnia), cataplexy, sleep paralysis, or hallucinations. Objective measures like the Epworth Sleepiness Scale (ESS) and Multiple Sleep Latency Test (MSLT) can help quantify daytime sleepiness and identify underlying sleep disorders. Consider implementing a structured approach to evaluating EDS by ruling out common causes like sleep-disordered breathing and other sleep disorders before referring patients to a sleep specialist for further investigation. Explore how diagnostic tests like polysomnography and MSLT can aid in accurate diagnosis and treatment planning.

Q: What are the best evidence-based non-pharmacological interventions for managing excessive daytime sleepiness in patients with diagnosed obstructive sleep apnea?

A: While treating the underlying obstructive sleep apnea (OSA) with Continuous Positive Airway Pressure (CPAP) therapy is the cornerstone of management, several non-pharmacological interventions can complement OSA treatment and further improve daytime somnolence. These include optimizing sleep hygiene practices (consistent sleep schedule, creating a relaxing bedtime routine), weight management strategies, and regular exercise. Addressing comorbidities like depression and anxiety can also positively impact EDS. Cognitive Behavioral Therapy for Insomnia (CBT-I) may be beneficial in patients who continue to experience sleep disturbances. Learn more about how integrating these interventions can enhance treatment outcomes for OSA patients and improve their quality of life.

Quick Tips

Practical Coding Tips
  • Code D hypersomnia if primary
  • Document EDS symptoms clearly
  • R/O other sleep disorders for EDS
  • Consider 780.54 for unspecified EDS
  • 780.97 if somnolence NOS

Documentation Templates

Patient presents with complaints of excessive daytime sleepiness (EDS), also known as daytime somnolence or hypersomnia.  The patient reports difficulty maintaining wakefulness during the day, experiencing unintended sleep episodes, and feeling unrefreshed after nighttime sleep.  This impacts their daily activities, including work performance and social functioning.  Onset of symptoms is reported as [onset duration - e.g., gradual over the past six months].  The patient denies any recent changes in sleep schedule or environment.  Review of systems reveals fatigue, difficulty concentrating, and potential cognitive impairment.  Differential diagnosis includes sleep apnea, narcolepsy, idiopathic hypersomnia, restless legs syndrome, and other sleep disorders.  Objective findings include [objective findings - e.g., Epworth Sleepiness Scale score of 18].  Assessment suggests a diagnosis of daytime somnolence, ICD-10 code G47.1.  Plan includes further evaluation to rule out underlying medical conditions contributing to EDS, such as hypothyroidism or iron deficiency anemia.  Referral to a sleep specialist is recommended for a comprehensive sleep study (polysomnography) and Multiple Sleep Latency Test (MSLT) to determine the underlying cause of the hypersomnia.  Patient education provided on sleep hygiene practices and potential treatment options, including behavioral therapy and pharmacological interventions such as modafinil.  Follow-up scheduled in [follow up duration - e.g., two weeks] to review sleep study results and discuss treatment plan.
Daytime Somnolence - AI-Powered ICD-10 Documentation